Evidence map›Paper›PMID 32934322›Full record

ArticleScientific reports2020

Advantage of fat-derived CD73 positive cells from multiple human tissues, prospective isolated mesenchymal stromal cells.

Eriko G Suto, Yo Mabuchi, Saki Toyota, Miyu Taguchi, Yuna Naraoka, Natsumi Itakura, Yoh Matsuoka, Yasuhisa Fujii, Naoyuki Miyasaka, Chihiro Akazawa

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. CD73Frontiers in cell and developmental biology · 2021
    Article
  13. Cellular Heterogeneity of Mesenchymal Stem/Stromal Cells in the Bone Marrow.Frontiers in cell and developmental biology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Eriko G SutoDepartment of Biochemistry and Biophysics, Graduate School of Health Care Sciences, Tokyo Medical and Dental University, Tokyo, 113-8510, Japan.
Yo MabuchiDepartment of Biochemistry and Biophysics, Graduate School of Health Care Sciences, Tokyo Medical and Dental University, Tokyo, 113-8510, Japan.
Saki ToyotaDepartment of Biochemistry and Biophysics, Graduate School of Health Care Sciences, Tokyo Medical and Dental University, Tokyo, 113-8510, Japan.
Miyu TaguchiDepartment of Biochemistry and Biophysics, Graduate School of Health Care Sciences, Tokyo Medical and Dental University, Tokyo, 113-8510, Japan.
Yuna NaraokaDepartment of Biochemistry and Biophysics, Graduate School of Health Care Sciences, Tokyo Medical and Dental University, Tokyo, 113-8510, Japan.
Natsumi ItakuraDepartment of Biochemistry and Biophysics, Graduate School of Health Care Sciences, Tokyo Medical and Dental University, Tokyo, 113-8510, Japan.
Yoh MatsuokaDepartment of Urology, Tokyo Medical and Dental University, Tokyo, 113-8510, Japan.
Yasuhisa FujiiDepartment of Urology, Tokyo Medical and Dental University, Tokyo, 113-8510, Japan.
Naoyuki MiyasakaDepartment of Perinatal and Women's Medicine, Tokyo Medical and Dental University, Tokyo, 113-8510, Japan.
Chihiro AkazawaDepartment of Biochemistry and Biophysics, Graduate School of Health Care Sciences, Tokyo Medical and Dental University, Tokyo, 113-8510, Japan. c.akazawa.gt@juntendo.ac.jp.
Tokyo Medical and Dental University · JPJuntendo University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Somatic stem cells have been isolated from multiple human tissues for their potential usefulness in cell therapy. Currently, mesenchymal stromal cells (MSCs) are prepared after several passages requiring a few months of cell culture. In this study, we used a prospective isolation method of somatic stem cells from gestational or fat tissues, which were identified using CD73 antibody. CD73-positive population from various tissues existed individually in flowcytometric pattern, especially subcutaneous fat- and amniotic-derived cells showed the highest enrichment of CD73-positive cells. Moreover, the cell populations isolated with the prospective method showed higher proliferative capacity and stem cell marker expression, compared to the cell populations which isolated through several passages of culturing whole living cells: which we named "conventional method" in this paper. Furthermore, the therapeutic potential of CD73-positive cells was evaluated in vivo using a mouse model of pulmonary fibrosis. After intranasal administration, murine CD73-positive cells reduced macrophage infiltration and inhibited fibrosis development. These results suggest that further testing using CD73-positive cells may be beneficial to help establish the place in regenerative medicine use.

Indexed as

Flow CytometryMesenchymal Stem Cell TransplantationPulmonary Fibrosis5'-NucleotidaseAnimalsCell Culture TechniquesDisease Models, AnimalFemaleGPI-Linked ProteinsHumansMaleMesenchymal Stem CellsMiceOrgan Specificity5'-NucleotidaseGPI-Linked ProteinsNT5E protein, human

Identifiers

PMID32934322
PMCPMC7493914
OpenAlexW3087391251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.